Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced Rare Tumours × Sunitinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 6 Gastrointestinal Stromal Tumors 3 Urologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Kidney Neoplasms 1 Kidney Diseases 1 Advanced Renal Cancer 1 Advanced Rare Tumours 1

Interventions

temsirolimus 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01396408 2025-03-18

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Canadian Cancer Trials Group

Phase 2 Active not recruiting

Advanced Rare Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡